Longevity & Ageing · Projected milestone
Senolytic medicines approved
Estimated year~2034
25% by 2039 · including earlier years
The year is an editorial timing estimate. The percentage applies to occurrence by the stated deadline. These estimates are not calibrated odds.
Zombie-cell-clearing drugs are approved for age-related diseases.
Explore this milestone on the interactive mapWhat the forecast means
Milestone stage: milestone (legacy definition)
Completion criteria: Legacy milestone: refine the observable threshold before resolving.
This page describes a forecast, rather than an achieved result. Read the methodology and assumptions.
Built on
Led to
Sources & evidence
No individual source links are recorded for this milestone. Source coverage and review status vary across the atlas.
Dataset updated 2026-10-18. This individual record has not been separately re-reviewed.